Evidence map›Paper›PMID 32060313›Full record

ArticleNature communications2020

Structural basis of mammalian high-mannose N-glycan processing by human gut Bacteroides.

Beatriz Trastoy, Jonathan J Du, Erik H Klontz, Chao Li, Javier O Cifuente, Lai-Xi Wang, Eric J Sundberg, Marcelo E Guerin

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Novel Endo-β-Foods (Basel, Switzerland) · 2025
    Article
  6. Mechanisms of uropathogenicScience advances · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Human Gut Metagenomes Encode Diverse GH156 Sialidases.Applied and environmental microbiology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Beatriz Trastoy *Structural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain. btrastoy@cicbiogune.es.ORCID http://orcid.org/0000-0002-2178-732X
Jonathan J Du *Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Erik H KlontzInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Chao LiDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, 20742, USA.ORCID http://orcid.org/0000-0002-8090-2017
Javier O CifuenteStructural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.ORCID http://orcid.org/0000-0001-5420-121X
Lai-Xi WangDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, 20742, USA.
Eric J SundbergInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. eric.sundberg@emory.edu.ORCID http://orcid.org/0000-0003-0478-3033
Marcelo E GuerinStructural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain. mrcguerin@cicbiogune.es.
University of Maryland, Baltimore · USCIC bioGUNE · ESUniversity of Maryland, College Park · USIkerbasque · ES

Funding

Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Covergent Chemoenzymatic Synthesis of Glycopeptides and GlycoproteinsR01GM080374 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2007 to 2021
$3.9M
Rationalizing glycoengineering strategies for immunotherapeutic antibodiesR01AI149297 · NIAID · EMORY UNIVERSITY · PI JEFFREY Victor RAVETCH, ERIC JOHN SUNDBERG · 2020 to 2026
$3.7M
Synthesis and Function of Antibody Fc Domain GlycoformsR01GM096973 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2011 to 2020
$2.4M
NIAID NIH HHS R01 AI149297NIAID NIH HHS T32 AI095190NIGMS NIH HHS R01 GM080374NIGMS NIH HHS R01 GM096973
6 · The paper itself

Abstract

The human gut microbiota plays a central role not only in regulating the metabolism of nutrients but also promoting immune homeostasis, immune responses and protection against pathogen colonization. The genome of the Gram-negative symbiont Bacteroides thetaiotaomicron, a dominant member of the human intestinal microbiota, encodes polysaccharide utilization loci PULs, the apparatus required to orchestrate the degradation of a specific glycan. EndoBT-3987 is a key endo-β-N-acetylglucosaminidase (ENGase) that initiates the degradation/processing of mammalian high-mannose-type (HM-type) N-glycans in the intestine. Here, we provide structural snapshots of EndoBT-3987, including the unliganded form, the EndoBT-3987-Man

Indexed as

Bacterial ProteinsBacteroides thetaiotaomicronGastrointestinal MicrobiomeGene Expression Regulation, BacterialGlycoside HydrolasesHumansMannosePolysaccharidesSubstrate SpecificityBacterial ProteinsGlycoside HydrolasesMannosePolysaccharides

Identifiers

PMID32060313
PMCPMC7021837
OpenAlexW3005922119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.